⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL75716 | 0.67 | — | — | |
| SCHEMBL2869462 | 0.65 | — | — | |
| SCHEMBL19559685 | 0.65 | — | — | |
| SCHEMBL94304 | 0.65 | — | — | |
| SCHEMBL96698 | 0.65 | — | — | |
| SCHEMBL4407943 | 0.65 | — | — | |
| SCHEMBL2070313 | 0.65 | — | — | |
| SCHEMBL18646682 | 0.65 | — | — | |
| SCHEMBL10752250 | 0.65 | — | — | |
| SCHEMBL2739417 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106029660-A | P2X 3 and/or P2X 2/3 compounds and methods | 阿萨纳生物科技有限责任公司 | 2016-10-12 | — | — | CN | claimed |
| US-12495798-B2 | Nicotinamide compound and herbicidal composition comprising compound | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2025-12-16 | — | — | US | disclosed |
| CN-114599644-B | Nicotinamide compound and herbicide composition containing the same | 韩国化学研究院 | 2024-08-02 | — | — | CN | disclosed |
| US-20240217966-A1 | PHARMACEUTICAL COMPOSITION CONTAINING GLP-1 RECEPTOR AGONIST HAVING FUSED RING | SHIONOGI & CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20230295220-A1 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | VIIV HEALTHCARE UK NO 5 LTD (GB) | 2023-09-21 | — | — | US | disclosed |
| US-20230295154-A1 | HETEROCYCLIC GLP-1 AGONISTS | SHOUTI INC. | 2023-09-21 | — | — | US | disclosed |
| EP-3831839-B1 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | VIIV HEALTHCARE UK NO 5 LTD (GB) | 2023-07-26 | — | — | EP | disclosed |
| US-20230165846-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. | 2023-06-01 | — | — | US | disclosed |
| US-20220386607-A1 | NICOTINAMIDE COMPOUND AND HERBICIDAL COMPOSITION COMPRISING COMPOUND | Farmhannong Co., Ltd. (KR) | 2022-12-08 | — | — | US | disclosed |
| EP-4050007-A1 | NICOTINAMIDE COMPOUND AND HERBICIDAL COMPOSITION COMPRISING COMPOUND | Korea Research Institute of Chemical Technology (KR) | 2022-08-31 | — | — | EP | disclosed |
| EP-0069373-A1 | (5R, 6R)-Penem compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1983-01-12 | — | — | EP | disclosed |
| US-4171439-A | Antibacterial analogs of isocephalosporins | BRISTOL-MYERS COMPANY (US) | 1979-10-16 | — | — | US | disclosed |
| US-4166905-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1979-09-04 | — | — | US | disclosed |
| US-4166906-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1979-09-04 | — | — | US | disclosed |
| US-4112230-A | Δ2,3 -1,4 Morpholine-2-carboxylic acid derivatives as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4068078-A | ANTIBIOTICS | BRISTOL-MYERS CORPORATION (US) | 1978-01-10 | — | — | US | disclosed |
| US-4068080-A | BETA-LACTAM ANTIBIOTICS, CEPHALOSPORIN ANALOGS | BRISTOL-MYERS COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-4068075-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1978-01-10 | — | — | US | disclosed |
| US-4066832-A | ANTIBIOTICS | BRISTOL-MYERS COMPANY (US) | 1978-01-03 | — | — | US | disclosed |
| US-4011216-A | Δ2,3-0-2-Isocephem-4-carboxylic acid and derivatives thereof as antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1977-03-08 | — | — | US | disclosed |